Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Dermatology

Journal Scan / Research · March 10, 2022

Risk of Adverse Drug Reaction While Treating Bacterial Skin Infections and Herpesviridae Infections With Ustekinumab, Secukinumab, and TNF-α Inhibitors

Acta Dermato-Venereologica

 

Additional Info

Disclosure statements are available on the authors' profiles:

Acta Dermato-Venereologica
Global Risk of Bacterial Skin Infections and Herpesviridae Infections with Ustekinumab, Secukinumab, and Tumour Necrosis Factor-alpha Inhibitors: Spontaneous Reports of Adverse Drug Reactions from the World Health Organization Pharmacovigilance Center
Acta Derm Venereol 2022 Feb 11;[EPub Ahead of Print], L Davidson, JMPA Van den Reek, F Van Hunsel, EMGJ De Jong, BJ Kullberg

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading